Equities

Pharmanutra SpA

Pharmanutra SpA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)57.00
  • Today's Change0.10 / 0.18%
  • Shares traded5.90k
  • 1 Year change+15.27%
  • Beta0.1956
Data delayed at least 15 minutes, as of Nov 13 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Wednesday, Pharmanutra SpA (PHN:MIL) closed at 57.00, -10.24% below its 52-week high of 63.50, set on Feb 15, 2024.
52-week range
Today
44.85Jun 12 202463.50Feb 15 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open56.80
High57.40
Low56.50
Bid54.50
Offer57.30
Previous close56.90
Average volume7.96k
Shares outstanding9.68m
Free float3.40m
P/E (TTM)37.72
Market cap550.85m EUR
EPS (TTM)1.51
EUR
Annual div (ADY)0.85
EUR
Annual div yield (ADY)1.49%
Div ex-dateMay 06 2024
Div pay-dateMay 08 2024
Data delayed at least 15 minutes, as of Nov 13 2024 16:35 GMT.
More ▼

Events & Activity

  • PHN:MIL reported earnings of 0.44 for the period of the year 2024Q3.
  • PHN:MIL price moved over -1.67% to 53.00
  • PHN:MIL price rises above 200-day moving average to 54.00 at 03:00 GMT
  • PHN:MIL price falls below 200-day moving average to 53.00 at 03:00 GMT
  • PHN:MIL trading volume exceeds daily average by +19.71%
  • PHN:MIL price rises above 15-day moving average to 55.00 at 03:42 GMT
  • PHN:MIL price rises above 15-day moving average to 55.70 at 09:47 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.